However, the anti-pre-ART SIV efficacy of CD8+ cells post-ART showed no significant correlation with Gag-specific nor Vif-specific CD8+ T-cell responses at week 27 post-infection (Fig. 5). This evidence concerns the gene CD8A and infection.